|
|
||||||||
1 From the Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan; 2 Shimizu Laboratory Supplies Company, Ltd., Kyoto, Japan; and the 3 Research Facilities for Laboratory Animal Science, Hiroshima University, School of Medicine, Hiroshima, Japan.
| Abstract |
|---|
|
|
|---|
METHODS. Fifty-five BN x (BN x UPL)F1 backcross rats and 133 BN x UPL intercross rats were produced. The cataracts present in the rats at eye opening were diagnosed as E-type. Cataracts that developed after eye opening were diagnosed as L-type, and the ages when complete opacity in the lens was observed were used as a quantitative trait to map a gene that modifies the development of mature cataracts. Linkage analysis was performed using 64 arbitrarily primed-representational difference analysis (AP-RDA) markers and 74 microsatellite markers.
RESULTS. A gene responsible for the formation of cataract was mapped to the vicinity of D2Rat134 on rat chromosome (chr) 2. A candidate gene, connexin 50 (Cx50/Gja8), had a C-to-T transition at codon 340 that is predicted to result in a nonconservative substitution of arginine by tryptophan. Recombination in the Cx50 genotype and formation of cataract was not observed. By quantitative trait loci analysis, a gene that modified the age of the development of mature cataract was mapped on rat chr 5.
CONCLUSIONS. A candidate gene for formation of cataracts in UPL rats was mapped to rat chr 2, and the Cx50 gene was a strong candidate. In addition, a potential modifier gene was mapped on chr 5. Future cloning of these genes will provide good targets for new therapies that can delay the progression of cataracts.
| Introduction |
|---|
|
|
|---|
The UPL rat was founded as a mutant with cataracts in a colony of Crj:SD (SD) rats at Tsukuba Research Laboratory, Upjohn Pharmaceuticals Limited, (Ibaraki, Japan) in 1989.7
Genetic analysis of the mutant showed that a single gene was semidominantly involved in the development of cataract.7
Homozygotes of UPL rats displayed early-onset (E-type) cataract, which manifested as lens opacification before eye opening at 14 days of age7
and was often accompanied by microphthalmos and/or buphthalmos.7
The differentiation of lens epithelial cells is known to be impaired in E-type UPL cataract.8
Heterozygotes of UPL rats displayed late-onset (L-type) cataract that started to appear at 2 to 4 weeks of age and developed into complete opacity of the lenses in both eyes (mature cataract) at 7 to 8 weeks of age.7
9
The initial change in the L-type cataract is hydration of the lens fibers at the anterior suture, and the hydration then spreads through the entire cortex of the lens.9
In both E-type and L-type cataracts, proteolyzed
-crystallin cannot be detected initially, but can be detected as the cataracts progress.10
The UPL rat shows no abnormalities in its lifespan, growth, and blood tests for hematology and chemistry and is considered a good model for congenital cataract, congenital microphthalmos, abnormal lens development (E-type), and various human cataracts (L-type). In spite of these, there is little knowledge of the gene responsible for the formation of cataract in the UPL rat.
In this study, we mapped the gene responsible for cataract in the UPL rat by linkage analysis. By using the ages when complete opacity in the lens was observed, we were also able to map a modifier gene in the mature cataract. By synteny analysis, a strong candidate gene for formation of cataract, rat Cx50, was identified, and its mutation in the UPL rat was demonstrated.
| Materials and Methods |
|---|
|
|
|---|
The lenses of rats were examined once a week with a direct ophthalmoscope and a slit lamp microscope, to observe any opacity in the lens. When rats had lens opacity at eye opening at the age of 2 weeks, E-type cataracts were diagnosed. When any lens opacity was observed by the age of 6 months, the rats were placed on further observation until complete opacity of the lens was observed in both eyes (mature cataracts). L-type cataracts were diagnosed in these rats, and the ages when mature cataracts developed were recorded. Rats that did not show any changes in the lenses by the age of 6 months were classified as noncataract. All animals were treated in accordance with the Guidelines for Animal Use of Hiroshima University, School of Medicine and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Genomic DNA was extracted from rat livers or tails by an automated DNA extractor (Genextractor TA-100; Takara Shuzo, Kyoto, Japan).
Genotyping Using AP-RDA Markers and Microsatellite Markers
Genotyping with the AP-RDA markers (http://www.ncc.go.jp/research/rat-genome/, provided in the public domain by the National Cancer Center Research Institute, Tokyo, Japan), which is suitable for genotyping of a large number of animals, was performed as reported previously.11
12
An AP amplicon of each rat was prepared by AP-PCR with an appropriate primer. The PCR solution was mixed with denaturing solution and dot blotted onto a nylon membrane (HyBond-N+; Amersham Biosciences, Uppsala, Sweden). Each of the AP-RDA markers was labeled using a random prime module (Gene Images; Amersham Biosciences), and hybridization/detection was performed with a chemiluminescence detection kit (Gene Images CDP-Star detection module; Amersham Biosciences).
Genotyping with microsatellite markers was performed as reported previously.13 PCR was performed with appropriate primers purchased from Research Genetics, Inc. (Huntsville, AL) using 20 ng of genomic DNA as a template. Electrophoresis of the PCR products was performed on a 4% agarose (NuSieve; Cambrex Corp., East Rutherford, NJ) gel in 0.5x TBE buffer. A rat coat color marker, Tyr, was genotyped by the presence of albino coat color. The 139 markers used in this study (64 AP-RDA markers, 74 microsatellite markers, and 1 coat color marker) are summarized in Table 1 . The genotypes UPL/UPL, UPL/BN, and BN/BN are denoted U/U, U/B, and B/B, respectively.
|
2 test. The ages of mature cataracts were log transformed and quantitative trait loci (QTL) analysis was performed using the gene-mapping software.15
Sequencing of the Rat Cx50 Gene and Analysis of Its Polymorphism
The coding sequences of rat Cx50 was amplified from genomic DNA in three fragments using three sets of forward (F) and reverse (R) primers based on the mouse Cx50 sequence (GenBank accession AF304357; GenBank is provided in the public domain by the National Center for Biotechnology Information, Bethesda, MD, and is available at http://www.ncbi.nlm.nih.gov/genbank): 1F, 5'-GAGTTGCACTGTGGCCAATT-3', 1R, 5'-CCACGATGAAGCCCACCTCA-3'; 2F, 5'-AGAAGTTCCGGCTGG-3', 2R, 5'-CTCCCACTTCCGGTTCCACA-3'; and 3F, 5'-CACTATTTCCCTTTGACG-3', 3R, 5'-CTAACAGCAGTTGGGATAGA-3'. Direct sequencing was performed with a kit and automated DNA sequencer (BigDye Terminator kit and ABI310 DNA sequencer; Applied Biosystems, Foster City, CA).
For PCR and restriction fragment length polymorphism (RFLP) analysis of Cx50, PCR was performed using primer 4F, 5'-GCCAAGCCTTTTAGTCAG-3' and 4R, 5'-TCACTAGGACAGTGGGTTTA-3', with an annealing temperature of 55°C. The PCR product was restricted with 5 U AciI (New England BioLabs, Beverly, MA) and run in a 2.0% agarose gel.
| Results |
|---|
|
|
|---|
|
Mapping of a Gene Responsible for Cataract
Backcross rats were genotyped with 42 AP-RDA markers and 71 microsatellite markers, with an average interval of 16.2 centimorgans (cM). F2 intercross rats were genotyped with 49 AP-RDA markers, 74 microsatellite markers, and one coat color marker with an average interval of 15.0 cM.
By linkage analysis with formation of cataract in the backcross rats (Table 3)
and the intercross rats (Table 3
; Fig. 1A
), a strong linkage was observed on rat chromosome (chr) 2 around D2Rat134. At D2Rat134, all the intercross rats with E-type cataract had the U/U genotype, and all the intercross rats with L-type cataract had the U/B genotype. However, rat 307, in which lens opacity was not observed at the age of 214 days, had the U/B genotype at D2Rat134 and the B/B genotype at D2Rat186, showing that the responsible gene was in a region between D2Rat134 and D2Rat186 (Fig. 1B)
. The gene responsible for formation of cataract was named Uca (UPL rat cataract). A comparative map among rat, mouse, and human chromosomes16
showed that the region between D2Rat134 and D2Rat118, the vicinity of Uca, corresponded to mouse chr 3 (3056 cM) and human chrs 3q25-q26, 1q21-q23, and 1p21-p13. In addition to Uca, weak and additional linkages were observed, only in the backcross rats, on chrs 4 and 16 (
2 = 8.6, P = 0.003 and
2 = 5.5, P = 0.02, respectively, Table 3 ).
|
|
|
PCR and direct sequencing were performed for the entire coding sequences in homozygotes of UPL and BN rats. A base substitution of T for C in codon 340, which is predicted to result in substitution of arginine by tryptophan (R340W), was observed in UPL rats (Fig. 3A) . The amino acid R340 was in the carboxyl terminus and was conserved between the rat and mouse (Fig. 3B) . For rapid detection of this mutation, PCR-RFLP analysis was developed based on the fact that a recognition site of the AciI enzyme (5'-GCGG-3') was disrupted by the mutation (Fig. 3C) . Using this PCR-RFLP marker, the 55 backcross and 133 intercross rats were genotyped. All 32 rats with E-type cataracts were homozygotes for this mutation, all 98 rats with L-type cataracts were heterozygotes, and all 58 rats without cataracts did not have the mutation (Fig. 3D) . The Cx50 gene was mapped as D2Rat134-(0.3 cM)-Cx50-(3.5 cM)-D2Rat186. Eleven strains of rats that do not have hereditary cataractsACI, BN, BUF, F344, Donryu, LEA, LEC, Lewis, SHRSP, Wistar Furth, and WKAHhad no mutation at R340 (data not shown).
|
| Discussion |
|---|
|
|
|---|
-1 (COL11A1)20
and beaded filament structural protein 2 (BFSP2).21
22
CX50 is abundantly expressed in the lens and oligomerizes with other connexins to form a connexon, one half of the gap junction channel that forms gap junctions.23
Missense mutations in codon 88 of CX50, located in the second membrane-spanning domain, are known to cause autosomal dominant "zonular pulverulent" type cataract in humans.18
The Cx50 mutations in codons 22 and 47 also have been suggested to cause cataract in mice,24
25
and Cx50-null mice exhibit microphthalmia and nuclear cataract.26
27
Based on these findings, we analyzed mutations of Cx50 in UPL rats and found the R340W mutation. There was no recombination between the mutation status and formation of cataract in the 55 backcross and 133 intercross rats. The R340W mutation was expected to result in a nonconservative amino acid change in the carboxyl terminus of Cx50. Although the carboxyl terminus is variable among different connexin members,28 it is conserved among animal species (Fig. 3B) . The carboxyl terminus contains phosphorylation sites for different kinases, and it is considered to be important for Cx50-specific functions.28 The nonconservative amino acid change in the carboxyl terminus could affect some of these functions of Cx50. Moreover, the R340W mutation was never observed in 11 rat strains that do not have hereditary cataracts. Therefore, Cx50 is a strong candidate for the Uca gene. A rescue experiment using a wild-type Cx50 transgene would be valuable in drawing a final conclusion.
QTL analysis using the ages of mature cataracts was performed in the intercross rats with L-type cataracts, all of which had the heterozygous R340W mutation in Cx50. By this QTL analysis, the Ucad1 gene was mapped to rat chr 5, and its BN genotype significantly delayed the development of mature cataract. This region corresponded to human chr 1p36-p33, and several candidate genes were found in the vicinity of this region. A cluster of four connexin genes, CX31, CX37, CX31.1, and CX30.3, was found in human 1p35.1. Forkhead transcription factor, FOXE3, the mutations of which are associated with anterior segment ocular dysgenesis and cataract,29 was found in human 1p32. Mutation of CX31 is known to cause deafness, but the functions of the other genes are unknown. When a rat had the B/B genotype in the Ucad1 locus, the development of cataract was delayed with the formation of L-type cataract, but formation occurred. Recent reports have shown that some of the functional defects caused by Cx50 deletion could be restored by other connexins, such as Cx46, but that some other defects could not be restored.27 30 Assuming that the Cx50 mutation is the Uca mutation, the probability that the Ucad1 gene is also one of the connexin genes is high. An incomplete Cx50 product in rats with heterozygous mutations could be compensated for by the contribution of another connexin to form connexon in the lens. The compensation effect is thought to be better performed by the BN-type than the UPL (SD)-type, but either type has enough activity to suspend the formation of cataract.
The Ucad1 gene explained 32.4% of the variance in the ages of mature cataracts, and its effect seems quite strong considering the large variance of the ages, even in inbred strains. The total effect of the BN background on the delay of formation of cataract can be assessed by comparing the original heterozygous UPL rat, which has the heterozygous Uca gene in the SD background, and a congenic strain that has the heterozygous Uca gene in the BN background. We are constructing such a congenic strain. Once the total effect of the BN background is assessed, the contribution of the Ucad1 gene can also be assessed accurately.
In this study, we successfully mapped a gene responsible for formation of cataract to chr 2 and a gene that modifies its development to rat chr 5. Cx50 is a strong candidate for the Uca gene. The molecular characterization of the Ucad1 gene will offer a good target for drug development that will delay the progression of cataract.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication February 5, 2002; revised May 17, 2002; accepted June 12, 2002.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Toshikazu Ushijima, Carcinogenesis Divison, National Cancer Center Research Institute, 1-1 Tsukiji 5-chome, Chuo-ku, Tokyo 104-0045, Japan; tushijim{at}ncc.go.jp.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
T. Kuramoto, S. Nakanishi, and T. Serikawa Functional polymorphisms in inbred rat strains and their allele frequencies in commercially available outbred stocks Physiol Genomics, April 21, 2008; 33(2): 205 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamashita, S. Suzuki, T. Nomoto, Y. Kondo, K. Wakazono, Y. Tsujino, T. Sugimura, T. Shirai, Y. Homma, and T. Ushijima Linkage and Microarray Analyses of Susceptibility Genes in ACI/Seg Rats: A Model for Prostate Cancers in the Aged Cancer Res., April 1, 2005; 65(7): 2610 - 2616. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Gerido, C. Sellitto, L. Li, and T. W. White Genetic Background Influences Cataractogenesis, but Not Lens Growth Deficiency, in Cx50-Knockout Mice Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2669 - 2674. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |